Company research
Amryt Pharma plc
CIK 1783010Updated Nov 16, 2026
Securities
Historical securities (1)
AMYT · NASDAQ · adr · closed Apr 12, 2023Name history
Amryt Pharma Holdings Ltd · through Aug 8, 2019
AMYT price & chart
Historical security
This listing closed Apr 12, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
cash flow · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Profit or LossUSD | 1,000,000Source | -104,527,000Source | -62,998,000Source |
| Additional Financial Items | |||
| AdjustmentsForSharebasedPaymentsUSD | 8,341,000Source | 4,729,000Source | 841,000Source |
| GoodwillUSD | 56,688,000Source | 19,131,000Source | 19,131,000Source |
| InterestPaidClassifiedAsFinancingActivitiesUSD | 12,283,000Source | 10,780,000Source | 6,253,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | 1,215,000Source | 1,119,000Source | 0Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD | 816,000Source | 963,000Source | 74,000Source |
income statement · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — |
| Selling, General and Administrative ExpenseUSD | 91,995,000Source | 76,673,000Source | 35,498,000Source |
| Total RevenueUSD | 222,543,000Source | 182,607,000Source | 58,124,000Source |
| Additional Financial Items | |||
| BasicEarningsLossPerShareUSD per share | 0Source | — | — |
| DeferredTaxExpenseIncomeRecognisedInProfitOrLossUSD | 62,395,001Source | 38,244,152Source | 25,858,892Source |
| DilutedEarningsLossPerShareUSD per share | 0Source | — | — |
| EmployeeBenefitsExpenseUSD | 64,330,000Source | 44,219,000Source | 23,470,000Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD | 8,341,000Source | 4,729,000Source | 841,000Source |
| ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsedUSD | 189,000Source | 623,000Source | 170,000Source |
| ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilitiesUSD | 0Source | 0Source | 0Source |
| GrossProfitUSD | 116,424,000Source | 63,578,000Source | 19,391,000Source |
| ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillUSD | 0Source | 0Source | 4,670,000Source |
| IncomeTaxExpenseContinuingOperationsUSD | -7,562,000Source | -1,332,000Source | -495,000Source |
| InterestExpenseOnLeaseLiabilitiesUSD | 558,000Source | 335,000Source | 17,000Source |
| OtherFinanceCostUSD | 27,906,000Source | 19,569,000Source | 4,759,000Source |
| PostemploymentBenefitExpenseDefinedBenefitPlansUSD | 1,643,000Source | 1,213,000Source | 769,000Source |
| PostemploymentBenefitExpenseDefinedContributionPlansUSD | 1,763,000Source | 1,284,000Source | 769,000Source |
| ProfitLossBeforeTaxUSD | -6,562,000Source | -105,859,000Source | -63,493,000Source |
| ProfitLossFromOperatingActivitiesUSD | -38,588,000Source | -46,459,000Source | -50,483,000Source |
| ResearchAndDevelopmentExpenseUSD | 37,729,000Source | 27,618,000Source | 15,827,000Source |
| RevenueFromInterestUSD | 5,000Source | -87,000Source | -92,000Source |